368 related articles for article (PubMed ID: 29414306)
21. Drug repurposing for breast cancer therapy: Old weapon for new battle.
Aggarwal S; Verma SS; Aggarwal S; Gupta SC
Semin Cancer Biol; 2021 Jan; 68():8-20. PubMed ID: 31550502
[TBL] [Abstract][Full Text] [Related]
22. Prioritization of candidate cancer drugs based on a drug functional similarity network constructed by integrating pathway activities and drug activities.
Di J; Zheng B; Kong Q; Jiang Y; Liu S; Yang Y; Han X; Sheng Y; Zhang Y; Cheng L; Han J
Mol Oncol; 2019 Oct; 13(10):2259-2277. PubMed ID: 31408580
[TBL] [Abstract][Full Text] [Related]
23. Drug Repurposing in the Development of Anticancer Agents.
Olgen S; Kotra LP
Curr Med Chem; 2019; 26(28):5410-5427. PubMed ID: 30009698
[TBL] [Abstract][Full Text] [Related]
24. Nitroxoline: repurposing its antimicrobial to antitumor application.
Mitrović A; Kos J
Acta Biochim Pol; 2019 Dec; 66(4):521-531. PubMed ID: 31834689
[TBL] [Abstract][Full Text] [Related]
25. An Insight into Drug Repositioning for the Development of Novel Anti-Cancer Drugs.
Bhattarai D; Singh S; Jang Y; Hyeon Han S; Lee K; Choi Y
Curr Top Med Chem; 2016; 16(19):2156-68. PubMed ID: 26881715
[TBL] [Abstract][Full Text] [Related]
26. Repositioning of fluoroquinolones from antibiotic to anti-cancer agents: An underestimated truth.
Yadav V; Talwar P
Biomed Pharmacother; 2019 Mar; 111():934-946. PubMed ID: 30841473
[TBL] [Abstract][Full Text] [Related]
27. Drug repurposing-an emerging strategy in cancer therapeutics.
Turabi KS; Deshmukh A; Paul S; Swami D; Siddiqui S; Kumar U; Naikar S; Devarajan S; Basu S; Paul MK; Aich J
Naunyn Schmiedebergs Arch Pharmacol; 2022 Oct; 395(10):1139-1158. PubMed ID: 35695911
[TBL] [Abstract][Full Text] [Related]
28. Repurposing drugs in oncology: From candidate selection to clinical adoption.
Pantziarka P; Verbaanderd C; Huys I; Bouche G; Meheus L
Semin Cancer Biol; 2021 Jan; 68():186-191. PubMed ID: 31982510
[TBL] [Abstract][Full Text] [Related]
29. Repurposing medicinal compounds for blood cancer treatment.
McCabe B; Liberante F; Mills KI
Ann Hematol; 2015 Aug; 94(8):1267-76. PubMed ID: 26048243
[TBL] [Abstract][Full Text] [Related]
30. Repurposing of FDA-approved drugs against cancer - focus on metastasis.
Ozsvári B; Lamb R; Lisanti MP
Aging (Albany NY); 2016 Apr; 8(4):567-8. PubMed ID: 27038638
[No Abstract] [Full Text] [Related]
31. Discovery of Small Molecule PARKIN Activator from Antipsychotic/Anti-neuropsychiatric Drugs as Therapeutics for PD: an In Silico Repurposing Approach.
Ibrahim A; Ipinloju N; Atasie NH; Babalola RM; Muhammad SA; Oyeneyin OE
Appl Biochem Biotechnol; 2023 Oct; 195(10):5980-6002. PubMed ID: 36735144
[TBL] [Abstract][Full Text] [Related]
32. Clinical Trials and Therapeutic Rationale for Drug Repurposing in Schizophrenia.
Lago SG; Bahn S
ACS Chem Neurosci; 2019 Jan; 10(1):58-78. PubMed ID: 29944339
[TBL] [Abstract][Full Text] [Related]
33. Repurposing existing therapeutics, its importance in oncology drug development: Kinases as a potential target.
Islam S; Wang S; Bowden N; Martin J; Head R
Br J Clin Pharmacol; 2022 Jan; 88(1):64-74. PubMed ID: 34192364
[TBL] [Abstract][Full Text] [Related]
34. Targeting Mevalonate Pathway in Cancer Treatment: Repurposing of Statins.
Iannelli F; Lombardi R; Milone MR; Pucci B; De Rienzo S; Budillon A; Bruzzese F
Recent Pat Anticancer Drug Discov; 2018; 13(2):184-200. PubMed ID: 29189178
[TBL] [Abstract][Full Text] [Related]
35. Repurposing Drugs for Cancer Prevention.
Lee DK; Szabo E
Curr Top Med Chem; 2016; 16(19):2169-78. PubMed ID: 26881711
[TBL] [Abstract][Full Text] [Related]
36. Repurposing of drugs as STAT3 inhibitors for cancer therapy.
Thilakasiri PS; Dmello RS; Nero TL; Parker MW; Ernst M; Chand AL
Semin Cancer Biol; 2021 Jan; 68():31-46. PubMed ID: 31711994
[TBL] [Abstract][Full Text] [Related]
37. Repurposing old drugs in oncology: Opportunities with clinical and regulatory challenges ahead.
Shah RR; Stonier PD
J Clin Pharm Ther; 2019 Feb; 44(1):6-22. PubMed ID: 30218625
[TBL] [Abstract][Full Text] [Related]
38. New HSP27 inhibitors efficiently suppress drug resistance development in cancer cells.
Heinrich JC; Donakonda S; Haupt VJ; Lennig P; Zhang Y; Schroeder M
Oncotarget; 2016 Oct; 7(42):68156-68169. PubMed ID: 27626687
[TBL] [Abstract][Full Text] [Related]
39. Drug repurposing: a new front in the war against Staphylococcus aureus.
Das S; Dasgupta A; Chopra S
Future Microbiol; 2016 Aug; 11():1091-9. PubMed ID: 27494302
[TBL] [Abstract][Full Text] [Related]
40. Repurposing approved non-oncology drugs for cancer therapy: a comprehensive review of mechanisms, efficacy, and clinical prospects.
Mohi-Ud-Din R; Chawla A; Sharma P; Mir PA; Potoo FH; Reiner Ž; Reiner I; Ateşşahin DA; Sharifi-Rad J; Mir RH; Calina D
Eur J Med Res; 2023 Sep; 28(1):345. PubMed ID: 37710280
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]